Granulomatous reaction to intradermal injection of lepromin (Mitsuda reaction) is linked to the human NRAMP1 gene in Vietnamese leprosy sibships

Journal of Infectious Diseases

Volumn 181, Issue 1, 2000, Pages 302-308

  Alcais A ^a   Sanchez, F O ^d   Thuc, N V ^e   Lap, V D ^e   Oberti, J ^c   Lagrange, P H ^b   Schurr, E ^d   Abel, L ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c INSERM   (France)

^d MCGILL UNIVERSITY   (Canada)

^e Dermatology and Venereology Hospital   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

LEPROMIN;

ARTICLE; CONTROLLED STUDY; GENE ACTIVITY; GENETIC LINKAGE; GENOTYPE; GRANULOMATOSIS; HUMAN; IMMUNE RESPONSE; LEPROMATOUS LEPROSY; MAJOR CLINICAL STUDY; MYCOBACTERIUM LEPRAE; PRIORITY JOURNAL; QUANTITATIVE TRAIT;

CARRIER PROTEINS; CATION TRANSPORT PROTEINS; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GRANULOMA; HAPLOTYPES; HUMANS; IMMUNITY, NATURAL; INJECTIONS, INTRADERMAL; LEPROMIN; LEPROSY; LEPROSY, LEPROMATOUS; LEPROSY, TUBERCULOID; LINKAGE (GENETICS); MALE; MEMBRANE PROTEINS; NUCLEAR FAMILY; PEDIGREE; PHENOTYPE; SKIN; T-LYMPHOCYTES, HELPER-INDUCER; VIETNAM;

EID: 0033978930     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315174     Document Type: Article

References (44)

1. 1. World Health Organization. Progress towards leprosy elimination. Wkly Epidemiol Rec 1997;72:165-72.
2. 2. Sansonetti P, Lagrange PH. The immunology of leprosy: speculations on the leprosy spectrum. Rev Infect Dis 1981;3:422-69.
3. 3. Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five groups system. Int J Lepr Other Mycobact Dis 1966;34:225-73.
4. 4. Godal T. Immunological aspects of leprosy: present status. Prog Allergy 1978;25:211-42.
5. 5. Vidal SM, Malo D, Vogan K, Skamene E, Gros P. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 1993;73:469-85.
6. 6. Cellier M, Govoni G, Vidal S, et al. Human natural resistance-associated macrophage protein: cDNA cloning, chromosomal mapping, genomic organization, and tissue specific expression. J Exp Med 1994;180:1741-52.
7. 7. Liu J, Fujiwara M, Buu NT, et al. Identification of polymorphisms and sequence variants in the human homologue of the mouse natural resistance-associated macrophage protein gene. Am J Hum Genet 1995;56: 845-53.
8. 8. Abel L, Sanchez FO, Oberti J, et al. Susceptibility to leprosy is linked to the human NRAMPI gene. J Infect Dis 1998;177:133-45.
9. 9. Roy S, Frodsham A, Saha B, Hazra SK, Mascie-Taylor CGN, Hill AVS. Association of vitamin D receptor genotype with leprosy type. J Infect Dis 1999;179:187-91.
10. 10. Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV. Variations in the NRAMPI gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998;338:640-4.
11. 11. Blackwell JM, Roach TI, Kiderlen A, Kaye PM. Role of Lsh in regulating macrophage priming/activation. Res Immunol 1989;140:798-805.
12. 12. Buschman E, Taniyama T, Nakamura R, Skamene E. Functional expression of the Bcg gene in macrophages. Res Immunol 1989;140:793 7.
13. 13. Buschman E, Schurr E, Skamene E. Constitutional resistance to mycobacterial infection: role of genetic factors in resistance to infection. In: Verduin CM, Watson DA, Van dijk H, Verhoef J, eds. Constitutional resistance to infection. Austin, TX: RG Landes, 1995:55-81.
14. 14. Beiguelman B. Leprosy and genetics: a review. Rev Bras Genet 1983;6:109-72.
15. 15. Languillon J. Classification immunologique de la lèpre. Bull Soc Pathol Exot 1964;57:424-31.
16. 16. Buu NT, Cellier M, Gros P, Schurr E. Identification of highly polymorphic-length variant in the 3UTR of NRAMPI. Immunogenetics 1995;42: 428-9.
17. 17. Spurr NK, Barton H, Bashir R. Report of the third international workshop on human chromosome 2 mapping. Cytogenet Cell Genet 1994; 67:215-14.
18. 18. Copeman JB, Cucca F, Hearne CM, et al. Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nat Genet 1995;9:80-5.
19. 19. Hoth CF, Engel W. Two RFLPs at the TNPI locus. Nucleic Acids Res 1991;19:69-79.
20. 20. Haseman JK, Elston RC. The investigation of linkage between a quantitative trait and a marker locus. Behav Genet 1972;2:3-19.
21. 21. Blackwelder WC, Elston RC. Power and robustness of sib-pair linkage tests and extension to larger sibships. Commun Stat Theor Methods 1982; 11: 449-84.
22. 22. Statistical analysis for genetic epidemiology. Cleveland: Department of Epidemiology and Biostatistics, Case Western Reserve University, 1994.
23. 23. Abel L, Alcaïs A, Mallet A. Comparison of four sib-pair linkage methods for analyzing sibships with more than two affecteds: interest of the binomial maximum-likelihood approach. Genet Epidemiol 1998;15: 371-90.
24. 24. Abel L, Müller-Myhsok B. Robustness and power of the maximum-likelihood-binomial and maximum-likelihood-score methods in multipoint linkage analysis of affected-sibship data. Am J Hum Genet 1998;63: 638-47.
25. 25. Alcais A, Abel L. Maximum-likelihood-binomial method for genetic model-free linkage analysis of quantitative traits in sibships. Genet Epidemiol 1999;17:102-17.
26. 26. Demenais FM, Lathrop M. REGRESS: a computer program including the regressive approach into the LINKAGE programs. Genet Epidemiol 1994;11:291.
27. 27. Feitosa M, Krieger H, Borecki I, Beiguelman B, Rao DC. Genetic epidemiology of the Mitsuda reaction in leprosy. Hum Hered 1996;46:32-5.
28. 28. Risch N, Zhang H. Extreme discordant sib-pairs for mapping quantitative trait loci in humans. Science 1995;268:1584-9.
29. 29. Gu C, Todorov A, Rao DC. Combining extremely concordant sib-pairs with extremely discordant sib-pairs provides a cost effective way to linkage analysis of quantitative trait loci. Genet Epidemiol 1996;13:513-33.
30. 30. Chaudhuri S, Hajra SK, Mukherjee A, et al. Why relapse occurs in PB leprosy patients after adequate MDT despite they are Mitsuda reactive: lessons from Convit's experiment on bacteria-clearing capacity of lepromin-induced granuloma. Int J Lepr Other Mycobact Dis 1998;66:182-9.
31. 31. Yeager JH, Azumi N, Underhill CB. Fibrosis: the formation of the granuloma matrix. In: Rom WN, SM Garay, eds. Tuberculosis. Boston: Little, Brown, 1995:363-70.
32. 32. Schurr E, Radzioch D, Malo D, Gros P, Skamene E. Molecular genetics of inherited susceptibility to intracellular parasites. Behring Inst Mitt 1991;88:1-12.
33. 33. Blackwell JM, Black GF, Sharples C, Soo SS, Peacock CS, Miller EN. Roles of Nrampl, HLA, and a gene(s) in allelic association with IL-4, in determining T helper subset differentiation. Microbes Infect 1999;1:95-102.
34. 34. Kaye PM, Curry AJ, Blackwell JM. Differential production of Th1-and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis. J Immunol 1991;146:2763-70.
35. 35. Kramnik I, Radzioch D, Skamene E. T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guérin-infected resistant and susceptible mice. Immunology 1994;81:618-25.
36. 36. Soo SS, Villarreal-Ramos B, Anjam Khan CM, Hormaeche CE, Blackwell JM. Genetic control of immune response to recombinant antigens carried by an attenuated Salmonella typhimurium vaccine strain: Nrampl influences T-helper subset responses and protection against leishmanial challenge. Infect Immun 1998;66:1910-7.
37. 37. Denis M, Forget A, Pelletier M, Skamene E. Pleiotropic effects of the Bcg gene. I. Antigen presentation in genetically susceptible and resistant congenic mouse strains. J Immunol 1988;140:2395-400.
38. 38. Kaye PM, Patel NK, Blackwell JM. Acquisition of cell-mediated immunity to Leishmania. II. Lsh gene regulation of accessory cell function. Immunology 1988;65:17-22.
39. 39. Kaye PM, Blackwell JM. Lsh, antigen presentation, and the development of CMI. Res Immunol 1989;140:810-22.
40. 40. Buschman E, Skamene E. Immunological consequences of innate resistance and susceptibility to BCG. Immunol Lett 1988;19:199-209.
41. 41. Kadhim SA, Chin JL, Batislam E, Karlik SJ, Garcia B, Skamene E. Genetically regulated response to intravesical bacillus Calmette Guérin immunotherapy of orthotopic murine bladder tumor. J Urol 1997;158: 646-52.
42. 42. Gordon S, Cohn ZA. Bacille Calmette-Guérin infection in the mouse. Regulation of macrophage plasminogen activator by T lymphocytes and specific antigen. J Exp Med 1978;147:1175-88.
43. 43. Vidal SM, Tremblay ML, Govoni G, et al. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nrampl gene. J Exp Med 1995;182:655-66.
44. 44. Sirova M, Hovorka O, Riha I, et al. The in vivo antibody response against exogenous antigens is not influenced by the mouse Bcg (Nrampl) gene. Immunology 1997;90:626-31.